MMB-2201
 | |
| Systematic (IUPAC) name | |
|---|---|
|
(S)-methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3-methylbutanoate | |
| Clinical data | |
| Legal status |
|
| Identifiers | |
| ChemSpider | 30922499 |
| Chemical data | |
| Formula | C20H27FN2O3 |
| Molar mass | 362.437 g/mol |
| |
| |
MMB-2201 (also known as 5F-MMB-PICA, 5F-AMB-PICA, and I-AMB) is an indole-3-carboxamide based synthetic cannabinoid, which has been sold as a designer drug and as an active ingredient in synthetic cannabis blends.[1] It was first reported in Russia and Belarus in January 2014, but has since been sold in a number of other countries. It is the indole core analogue of 5F-AMB. Synthetic cannabinoid compounds with an indole-3-carboxamide or indazole-3-carboxamide core bearing a N-1-methoxycarbonyl group with attached isopropyl or t-butyl substituent, have proved to be much more dangerous than older synthetic cannabinoid compounds previously reported, and have been linked to a large number of deaths in Russia, Japan, Europe and the United States.[2][3]
Legality
MMB-2201 is illegal in Russia, Belarus and Sweden.[4]
See also
References
- ↑ "MMB-2201". Cayman Chemical. Retrieved 16 July 2015.
- ↑ V. A. Shevyrin, Yu. Yu. Morzherin, V. P. Melkozerov, A. S. Nevero (July 2014). "New Synthetic Cannabinoid – Methyl 2-{[1-(5-Fluoro-Pentyl)-3-Methyl-1H -Indol-3-Ylcarbonyl]-Amino}Butyrate – as a Designer Drug" (PDF). Chemistry of Heterocyclic Compounds 50 (4): 583–586. doi:10.1007/s10593-014-1511-6.
- ↑ Shevyrin V, Melkozerov V, Nevero A, Eltsov O, Shafran Y, Morzherin Y, Lebedev AT (Apr 2015). "Identification and analytical characteristics of synthetic cannabinoids with an indazole-3-carboxamide structure bearing a N-1-methoxycarbonylalkyl group". Analytical and Bioanalytical Chemistry 407: 6301–15. doi:10.1007/s00216-015-8612-7. PMID 25893797.
- ↑ "Cannabinoider föreslås bli klassade som hälsofarlig vara". Folkhälsomyndigheten. Retrieved 29 June 2015.